Showing results (1-10 of 1,866) with videos related to

Sort By:
Pageof 187
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1992
Hypercholesterolemia after chemotherapy for testis cancerD Raghavan, K Cox, A Childs, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1992
Severe vascular adverse effects with thrombocytopenia and renal failure following emetogenic chemotherapy and ondansetronA S Coates, A Childs, K Cox, et al.
British Journal of Urology|May 1, 1992
Phase II clinical trial of recombinant alpha-2 interferon for biopsy-proven metastatic or recurrent renal carcinomaM A Rosenthal, K Cox, D Raghavan, et al.
The Australian and New Zealand Journal of Surgery|February 23, 2010
The treatment of disseminated prostate cancer with estramustineM A Rosenthal, D Raghavan, R Stuart-Harris, et al.
British Journal of Urology|November 1, 1993
Oral cyclophosphamide for the management of hormone-refractory prostate cancerD Raghavan, K Cox, B S Pearson, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1986
Phase I and pharmacokinetic study of tiazofurin (NSC 286193) administered by 5-day continuous infusionD Raghavan, J Bishop, D Sampson, et al.
The Medical Journal of Australia|May 18, 1992
Combination chemotherapy with cisplatin, vindesine and mitomycin-C for advanced, inoperable non-small-cell lung cancerM Stockler, D Raghavan, B C McCaughan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1994
Multiple atypical nevi: a cutaneous marker of germ cell tumorsD Raghavan, J R Zalcberg, J J Grygiel, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
A randomised cross-over trial of antiemetic therapy for platinum-based chemotherapy. Improved control with an intensive multiagent regimenM Findlay, R J Simes, K Cox, et al.
Pageof 187